it is the largest clinical trial in India for a COVID-19 vaccine. The firm has generated safety and immunogenicity data in various animal species such as mice, rats, rabbits, Syrian hamster, and also conducted challenge
India, one of the world’s biggest suppliers of vaccines, is facing a COVID-19 vaccine crunch, partly due to an explosion of cases linked to new variants. This spells trouble for many countries relying on Indian-made vaccines supplied through the COVAX initiative for equitable access to ...
COVAXIN®, India's indigenousCOVID-19 vaccineby Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV). The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech'sBSL-3 (Bio-Safety Level 3...
India is ready to mass produce COVID-19 vaccines when scientists give the go-ahead, Indian Prime Minister Narendra Modi said in his Independence Day speech on Saturday, also launching a national project to roll out health identities for each citizen. Modi identified health and economic sel...
Covid-19 Vaccine Hesitancy to Insufficiency in India; A Public Health view on Covid-19 Vaccination in IndiaGopinathan SamundeswariKumar PradeepRajasekar NiranjanAriarathinam Newtonraj
COVID-19 cases are surging fast in India, hence the commencement of the clinical trials for the vaccine has raised great hope and brought a sense of relief in the common people. However, as any proposed viral vaccine may have important safety risks for the clinical trial participants, and ...
A COVID-19 vaccine designed to be inexpensive and easy to mass produce globally has received emergency use authorization from India’s government,
The Drugs Control General of India has permitted emergency use of Covid vaccine Sputnik V with certain conditions, clearing the way for a third vaccine in addition to Covishield and Covaxin. Besides, the government on Tuesday also fast-tracked emergency approval for other jabs. Here is what the...
Almost 90 percent of the shots were produced by the Serum Institute of India, which produced a version of the AstraZeneca vaccine. Take a look. The China ReportSubscribe here!
According to the ministry, about 96 percent of the population who are 15 and above have received at least one COVID-19 vaccine dose while about 83 percent of this group have received two doses.■